Chameleonic properties make large molecules into possible drugs
In a paper published today in Nature Chemical Biology, a team of researchers from Uppsala University/SciLifeLab, the Broad Institute of MIT, Harvard, and AstraZeneca are presenting new insights into how larger-than-average molecules can be developed into pharmaceutical drugs.
